William H. Miller, Ph.D., the Principal Consultant at MedChem Innovations, LLC, is an accomplished “drug hunter” with over 29 years of experience in preclinical drug discovery research in the pharmaceutical industry. His credentials include:
Dr. Miller earned a BS in chemistry (with honors) from the University of Connecticut, graduating Magna Cum Laude. He then went on to earn a Ph.D. in synthetic organic chemistry at Yale University, under the direction of Professor Samuel J. Danishefsky. Dr. Miller then moved to Harvard University, where he worked as an NIH postdoctoral fellow for two years in the labs of Professor Yoshito Kishi. Following the completion of his academic studies, Dr. Miller began his industrial career as a medicinal chemist in 1989, initially in the Medical Products Division at DuPont, which later became the DuPont Merck Pharmaceutical Company. In 1991, Dr. Miller moved to SmithKline Beecham Pharmaceuticals, which became GlaxoSmithKline (GSK) in 2000. He worked at GSK for over 27 years before retiring in 2019.